Back
Beam Therapeutics Stock Price Chart
![](/images/offers/ims/large/offer3.jpg)
Wall Street's Worst Nightmare: Small Town Trader's AI Edge
See the AI advantage for everyday Americans.
Buy
71
BEAM
Beam Therapeutics
Last Price:
33.16
Seasonality Move:
-10%
7 Day Trial
ALL ACCESS PASS
$
7
![](/images/offers/ims/large/offer2.jpg)
Free presentation on how to trade options for overnight gains
Get the free overnight options training here.- Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and BEAM is experiencing slight buying pressure.
Beam Therapeutics Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.12 | Buy |
20-day SMA: | 25.73 | Buy |
50-day SMA: | 24.85 | Buy |
200-day SMA: | 26.85 | Buy |
8-day EMA: | 28.63 | Buy |
20-day EMA: | 26.68 | Buy |
50-day EMA: | 25.68 | Buy |
200-day EMA: | 27.47 | Buy |
Beam Therapeutics Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 1.51 | Buy |
Relative Strength Index (14 RSI): | 71.92 | Buy |
Chaikin Money Flow: | 640167 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (22.93 - 27.83) | Buy |
Bollinger Bands (100): | (22.12 - 31.68) | Buy |
Beam Therapeutics Technical Analysis
Jul 12 | Jul 15 | Jul 16 | Jul 17 | Jul 18 | Jul 19 | Jul 22 | Jul 23 | Jul 24 | Jul 25 | |
---|---|---|---|---|---|---|---|---|---|---|
Jul | ||||||||||
12 | 15 | 16 | 17 | 18 | 19 | 22 | 23 | 24 | 25 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Beam Therapeutics Stock
Is Beam Therapeutics Stock a Buy?
- Beam Therapeutics share price is 32.14 while BEAM 8-day simple moving average is 28.12, which is a Buy signal.
- The stock price of BEAM is 32.14 while Beam Therapeutics 20-day SMA is 25.73, which makes it a Buy.
- Beam Therapeutics 50-day simple moving average is 24.85 while BEAM share price is 32.14, making it a Buy technically.
- BEAM stock price is 32.14 and Beam Therapeutics 200-day simple moving average is 26.85, creating a Buy signal.
BEAM Technical Analysis vs Fundamental Analysis
Buy
71
Beam Therapeutics (BEAM)
is a Buy
Is Beam Therapeutics a Buy or a Sell?
-
Beam Therapeutics stock is rated a Buy
The current Beam Therapeutics [BEAM] share price is $32.14. The Score for BEAM is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
Beam Therapeutics Stock Info
Market Cap:
2.65B
Price in USD:
32.14
Share Volume:
2.34M
Beam Therapeutics 52-Week Range
52-Week High:
49.50
52-Week Low:
16.95
Buy
71
Beam Therapeutics (BEAM)
is a Buy
Beam Therapeutics Share Price Forecast
-
What is the Beam Therapeutics stock price today?
The Beam Therapeutics stock price is 32.14 USD today. -
Will BEAM stock go up or go down?
Beam Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Beam Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Beam Therapeutics is not overvalued.
Is Beam Therapeutics Stock a Buy?
- Beam Therapeutics share price is 32.14 while BEAM 8-day exponential moving average is 28.63, which is a Buy signal.
- The stock price of BEAM is 32.14 while Beam Therapeutics 20-day EMA is 26.68, which makes it a Buy.
- Beam Therapeutics 50-day exponential moving average is 25.68 while BEAM share price is 32.14, making it a Buy technically.
- BEAM stock price is 32.14 and Beam Therapeutics 200-day simple moving average is 27.47, creating a Buy signal.
Fundamental Analysis of Beam Therapeutics
Is Beam Therapeutics a good investment?
- Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.03 per share, a decrease this year of $0.48 per share, and an increase next year of $0.06 per share.
Technical Analysis of Beam Therapeutics
Should I short Beam Therapeutics stock?
- BEAM Moving Average Covergence Divergence (MACD) indicator is 1.51, suggesting Beam Therapeutics is a Buy
- Beam Therapeutics Relative Strength Index (RSI) is 71.92, which suggest Beam Therapeutics is overbought
- The Bollinger Bands (25) for Beam Therapeutics is (22.93 - 27.83), which suggest Beam Therapeutics is a Buy
- The Bollinger Bands (100) for Beam Therapeutics is (22.12 - 31.68), which suggest Beam Therapeutics is a Buy
* Beam Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.